Positions

Overview

  • Catherine Parker is a breast surgical oncologist at the UAB Multidisciplinary Breast Clinic, a clinic in which medical oncologists, surgeons and radiation oncologists work together to see approximately 450 new breast cancer cases each year. She is a member of the UAB Breast Cancer Prevention and Risk Assessment Clinic.

    Dr. Parker is a fellowship trained breast surgical oncologist with primary research interests in prevention and risk assessment of breast cancer, as well as breast cancer tumor biology and impact on treatment outcomes. She is an associate scientist with the Comprehensive Cancer Center and the Minority Health and Research Center.

    Dr. Parker received her M.D. degree from the Louisiana State University Health Sciences Center in 2008. She completed a residency in General Surgery also at the Louisiana State University in 2013. After surgical residency, she completed a Fellowship in Breast Surgery at M.D. Anderson Cancer Center in Houston, Texas. Since entering academic practice in July 2014, she has been actively involved in the education of medical students and residents on a daily basis.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2019 The impact of breast lumpectomy tray utilization on cost savingsJournal of Surgical Research.  233:32-35. 2019
    2018 Treatment patterns for ductal carcinoma in situ with close or positive mastectomy marginsJournal of Surgical Research.  231:36-42. 2018

    Research Overview

  • breast cancer, tumor biology, outcomes research
  • Investigator On

  • ECOG-ACRIN Purchase Service Agreement  awarded by Eastern Cooperative Oncology Group 2019 - 2024
  • XUAB 17109-TBCRC 038: Diversity in the Tumor Genome and Microenvironment as Drivers of DCIS Progression  awarded by Johns Hopkins University 2018 - 2023
  • Private Grant  awarded by VARIAN MEDICAL SYSTEMS, INC. 2019 - 2022
  • Private Grant  awarded by Genentech 2016 - 2021
  • Preoperative Pectoral Nerve Block to Decrease Acute and Chronic Post-Operative Pain and Narcotic use Following Mastectomy  awarded by UNIVERSITY OF ALABAMA HEALTH SERVICES FOUNDATION 2018 - 2020
  • Enabling A Paradigm Shift: A Preference-Tolerant RCT of Personalized vs Annual Screening of Breast Cancer (WISDOM)  awarded by QUANTUM LEAP HEALTH CARE 2018 - 2020
  • TBCRC 038: Diversity in the Tumor Genome and Microenvironment as Drivers of DCIS Progession  awarded by Duke University 2018 - 2020
  • TBCRC 037 UAB 1644:A Trial of Endocrine Response In Women with Invasive Lobular Breast Cancer.  awarded by University of Pittsburgh 2016 - 2020
  • ECOG-ACRIN Purchase Service Agreement  awarded by Eastern Cooperative Oncology Group 2014 - 2020
  • Phase Ib 9cUAB30 in Early Stage Breast Cancer to Evaluate Biologic Effect  awarded by University of Wisconsin-Madison 2016 - 2019
  • UAB NRG Oncology Member Institution Purchased Service Agreement  awarded by NRG ONCOLOGY FOUNDATION 2015 - 2019
  • Prospective Study of MRI and Multi-Parameter Gene Expression Assay in Ductal Carcinoma in Situ (DCIS) (R15-037)  awarded by American College of Radiology Imaging Network 2015 - 2017
  • Education And Training

  • Doctor of Medicine, Louisiana State University System : Shreveport 2008
  • LSU Medical Center, Internship 2009
  • LSU Medical Center, Residency 2013
  • MD Anderson Cancer Center, Postdoctoral Fellowship 2014
  • Full Name

  • Catherine Parker